HKSE · 6618.HK
JD Health International Inc.
HK$38.24+HK$2.26 (+6.28%)
JD Health International Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.67% below the high.
Loading market information…
HKSE · 0241.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:22 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Alibaba Health Information Technology Limited’s quoted price sits in the lower half of its reported 52-week range, 64.22% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Alibaba Health Information Technology Limited’s next earnings report is currently expected on Dec 1, 2026, with estimated earnings per share of HK$0.08. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Alibaba Health Information Technology Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical consultation, appointment-booking, vaccination, dental and mental care, optometry, and nursing services, as well as traditional chinese medicines. The company provides products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark. In addition, it engages in the digital tracking business; asset management; network hospital, software technical services, healthcare related internet information and technical services and research; operation of internet hospitals, as well as Alibaba Health, flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:37 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| HK$15.23B+13.25% vs estimate |
| Q2 2024 | Nov 27, 2023 | HK$0.04+228.89% vs estimate | HK$13.90B+0.57% vs estimate |
|---|
| Q4 2023 | May 23, 2023 | HK$0.030.0% vs estimate | HK$17.45B+7.07% vs estimate |
|---|
| Q2 2023 | Nov 28, 2022 | HK$0.01 | HK$12.69B-0.72% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$38.24+HK$2.26 (+6.28%)
JD Health International Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.67% below the high.
HK$4.82-HK$0.04 (-0.72%)
Sino Biopharmaceutical Limited’s quoted price sits in the lower half of its reported 52-week range, 35.63% below the high.
HK$35.34-HK$2.36 (-6.26%)
Genscript Biotech Corporation’s quoted price sits in the upper half of its reported 52-week range, 28.55% below the high.
HK$38.70+HK$1.40 (+3.75%)
Fameglow Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 15.28% below the high.
HK$5.42+HK$0.15 (+2.75%)
Ping An Healthcare and Technology Company Limited’s quoted price sits in the lower half of its reported 52-week range, 71.15% below the high.
HK$0.98-HK$0.01 (-0.51%)
Xikang Cloud Hospital Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.34% below the high.
HK$3.38-HK$0.52 (-13.33%)
QingSong Health Corp’s quoted price sits in the lower half of its reported 52-week range, 97.92% below the high.
HK$0.73-HK$0.05 (-6.45%)
HealthyWay Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.72% below the high.
